Advisors Asset Management, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisors Asset Management, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$136,000
-32.0%
56,626
-22.5%
0.00%
-33.3%
Q4 2017$200,000
-49.6%
73,024
-37.6%
0.00%
-57.1%
Q3 2017$397,000
-3.6%
116,964
-29.8%
0.01%0.0%
Q2 2017$412,000
-36.5%
166,633
-41.7%
0.01%
-36.4%
Q1 2017$649,000
-1.2%
285,816
-7.8%
0.01%0.0%
Q4 2016$657,000
-59.2%
309,914
-35.6%
0.01%
-57.7%
Q3 2016$1,611,000
-62.1%
480,943
-64.5%
0.03%
-62.3%
Q2 2016$4,255,000
-45.9%
1,355,242
-42.6%
0.07%
-47.3%
Q1 2016$7,866,000
-34.8%
2,362,054
-30.7%
0.13%
-31.4%
Q4 2015$12,061,000
-47.6%
3,406,970
-25.5%
0.19%
-48.0%
Q3 2015$23,018,000
-33.4%
4,576,168
-14.8%
0.37%
-22.6%
Q2 2015$34,549,000
-7.3%
5,373,113
+1.4%
0.47%
-4.4%
Q1 2015$37,261,000
-3.3%
5,296,448
+5.9%
0.50%
-4.1%
Q4 2014$38,548,000
+6.5%
4,999,729
+3.2%
0.52%
+3.6%
Q3 2014$36,198,000
-20.9%
4,845,785
+2.5%
0.50%
-21.3%
Q2 2014$45,761,000
+49.8%
4,727,365
+28.6%
0.63%
+36.9%
Q1 2014$30,543,000
+8.3%
3,675,485
+10.0%
0.46%
+1.8%
Q4 2013$28,212,000
+15.6%
3,342,638
+9.2%
0.46%
+5.1%
Q3 2013$24,406,000
+40.7%
3,062,239
+36.3%
0.43%
+32.0%
Q2 2013$17,346,0002,246,8860.33%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2017
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders